HealthEquity Closes Acquisition of BenefitWallet HSA Portfolio
DRAPER, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity"), the leader in Health Savings Account (HSA)...
Month: May 2024
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
BETHESDA, Md., May 14, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
FitLife Brands Announces First Quarter 2024 Results
Omaha, May 14, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative...
Delcath Systems Reports First Quarter 2024 Results and Business Highlights
Conference Call Today at 8:30 am Eastern Time QUEENSBURY, N.Y., May 14, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH)...
4Front Ventures to Report First Quarter 2024 Financial Results on May 17, 2024
PHOENIX, May 14, 2024 /PRNewswire/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company"), a vertically integrated multi-state...
NowVertical Welcomes David Doritty as Independent Director
TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (“NowVertical” or the “Company”) (TSX-V: NOW) (OTCQB: NOWVF), is pleased...
UniDoc Expands AI Capabilities to Emergency Room Patients
-- Enhanced Monitoring and Predictive Analytics Designed to Improve Patient Care VANCOUVER, BC, May 14, 2024 /PRNewswire/ - UniDoc Health Corp. (CSE:...
Petosemtamab erhielt von der FDA der USA die Breakthrough Therapy Designation
• Petosemtamab erhielt die BTD für die Behandlung von bereits behandeltem HNSCCUTRECHT, Niederlande und CAMBRIDGE, Massachusetts, May 14, 2024 (GLOBE...
Laser Photonics Announces First Quarter 2024 Results
Revenue increased 10%; reduced operating loss by 39%; reduced net loss and diluted loss per share by 57% each ORLANDO,...
Crown Crafts Announces Quarterly Cash Dividend
GONZALES, La., May 14, 2024 (GLOBE NEWSWIRE) -- Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) announced today that its Board...
CRN Recognizes 7 Employees at Climb Channel Solutions on the 2024 Women of the Channel List and Names Climb’s VP of Marketing Worldwide as one of the 2024 Women of the Channel Power 100
EATONTOWN, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary...
Broadwind Announces First Quarter 2024 Results
CICERO, Ill., May 14, 2024 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized...
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
RESEARCH TRIANGLE PARK, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) today announced that new data...
Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences
̶ Results from Long-Term Safety Study and Data from Healthcare Resource Utilization Research Offer Insights into Treatment Experiences for People...
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
CHARLOTTESVILLE, Va., May 14, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical...
Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
NEW YORK and SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...
Veritone Announces Strategic Partnership with Creative Artists Agency for the Launch of theCAAvault
Collaboration between Veritone and CAA strengthens data and identity security and underscores AI’s positive impact across the entertainment industry Contacts...
CryoMass Announces Sale of First Production Model to be deployed in Canada
DENVER, May 14, 2024 (GLOBE NEWSWIRE) -- CryoMass Technologies Inc. (the “Company” or “CryoMass”) (OTCQB: CRYM), a pioneering leader in...
Synlogic Reports First Quarter 2024 Financial Results
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform...
SkyWater Florida Achieves DMEA Category 1A Trusted Supplier Accreditation
Contacts SkyWater Company Contact: Tara Luther | +1 952-851-5023 | tara.luther@skywatertechnology.com SkyWater Media Contact: Lauri Julian | +1 949-280-5602 |...
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
PHILADELPHIA, May 14, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on...
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
Company reports Q1 2024 XHANCE net revenue of $14.9 million, an increase of 26% compared to Q1 2023Company expects full...
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
- Generated first quarter 2024 CGuard EPS revenue of $1.51 million, an increase of 22.0% over the first quarter of...
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
Potential to alleviate unmet need associated with depressed mood and anhedonia in bipolar depression; navacaprant has demonstrated the ability to...
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
Mural’s lead product candidate, nemvaleukin alfa, is in two potentially registrational trials in platinum resistant ovarian cancer and mucosal melanoma,...
New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction
THE WOODLANDS, Texas, May 14, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a new post-hoc analysis...
Immatics Announces First Quarter 2024 Financial Results and Business Update
Company Provides Clinical Data Update from Ongoing Phase 1 Clinical Trial with ACTengine® IMA203 TCR-T Targeting PRAME Read more at...
Hydrofarm Holdings Group Announces First Quarter 2024 Results
SHOEMAKERSVILLE, Pa., May 14, 2024 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading...
Exscientia to Report First Quarter 2024 Financial Results on May 21, 2024
Company to host conference call and webcast on May 21, 2024, at 1:30 p.m. BST / 8:30 a.m. EDT Contacts...
EVgo Doubles Down on Commitment to Begin NACS Deployments in 2024
Seismic shift in competitive landscape opens opportunity to further drive utilization of the EVgo network, expand footprint with new site...
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in Phase 1...
Castle Biosciences Expands Evidence Supporting the Performance of its TissueCypher® Barrett’s Esophagus Test in Predicting Future Development of Esophageal Cancer Through Multiple Data Presentations at DDW 2024
In collaboration with leading GI experts, Castle has also planned several educational sessions at DDW 2024, including a product theater...
Azimut présente le programme d’exploration planifié sur Pilipas, région de la Baie James, Québec
LONGUEUIL, Québec, 14 mai 2024 (GLOBE NEWSWIRE) -- Exploration Azimut Inc. (« Azimut » ou la « Société ») (TSXV : AZM) (OTCQX : AZMTF) annonce...
Azimut Updates on Surface Program Planned at Pilipas, James Bay Region, Quebec
LONGUEUIL, Quebec, May 14, 2024 (GLOBE NEWSWIRE) -- Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to...
Gabelli Funds Names Scott Donnelly, Robert Kotick, Greg Maffei and Tony Najjar to Management Hall of Fame
Contacts Douglas R. Jamieson President & Chief Operating Officer (914) 921-5020 For further information please visit www.gabelli.com Gabelli Funds introduced...
Satellos Bioscience Announces Q1 2024 Financial Results and Operational Highlights
- Conducted preclinical toxicology studies and GMP manufacturing of SAT-3247 - On track to initiate Phase 1 first-in-human clinical trials...
MetaWorks’ New Venture, Energy Works, Inc., to Revolutionize Plastic Waste Management with Cutting-Edge Diesel Fuel Conversion
Company Prepares for Groundbreaking Machine Launch in Q4 2024Fairfield, CA., May 14, 2024 (GLOBE NEWSWIRE) -- MetaWorks Platforms, Inc. ("MetaWorks"...
POSaBIT Reports Fourth Quarter and Annual 2023 Financial Results
2023 Overall Revenue Growth of 23% Excluding Licensing 2023 Point of Sale Revenue Growth of 51% 2023 Payment Revenue Growth...
Kolibri Global Energy Inc. Announces Bank Line Increase to $50 Million
Contacts For further information: Wolf E. Regener +1 (805) 484-3613 Email: wregener@kolibrienergy.com Website: www.kolibrienergy.com Kolibri Global Energy Inc. (the “Company”...
Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update
Management to host a conference call today at 8:30 am ETWM pivotal study data to be announced in JuneFLORHAM PARK,...